Education, research notes, and product intelligence.
Fresh editorial content for peptide research, skincare science, wellbeing categories, Svelta-GPT updates, and research-use product guidance.
Restarting Mounjaro After Weight Regain: A Lived Experience Perspective
Many individuals experience weight fluctuations after stopping medications like Mounjaro. This article explores a personal experience of restarting Mounjaro following some weight regain, highlighting common themes and considerations.
Understanding Experiences When Switching from Mounjaro to Wegovy
Exploring community perspectives on transitioning between Mounjaro and Wegovy, two peptide-related medications with differing mechanisms, highlighting lived experiences and research context.
Starting a Mounjaro Journey: Insights from Lived Experience
This article explores a personal account of starting Mounjaro, highlighting challenges with portion control, peri menopause, and ADHD, and emphasising the importance of mindset and support.
Understanding Off-Label Weight Loss Injections for BMI Under 27: A Lived Experience Perspective
This article explores the lived experiences shared in online communities regarding off-label use of weight loss injections for individuals with a BMI under 27. It highlights the importance of understanding current research, regulatory context, and product literacy.
Community Insights on Retatrutide’s Limited US Rollout and Regulatory Pathway
Retatrutide, a next-generation obesity drug, is generating community discussion around its regulatory timeline and classification as a biologic. This article examines these perspectives alongside regulatory context and potential implications.
Starting Mounjaro: Navigating First-Time Injection Nerves
Beginning a new injectable treatment like Mounjaro can bring excitement alongside understandable nerves. This article explores common feelings and practical advice for first-time injectors.
Starting Mounjaro: A Lived Experience Perspective on Weight Management Support
Many individuals seek additional support for weight management beyond exercise and diet. This article discusses a personal account of starting Mounjaro, highlighting common challenges and the importance of understanding emerging treatment options.
Understanding Expiry Dates and Supply for Mounjaro Injections: Lived Experience Insights
Exploring lived experiences around expiry dates and supply intervals for Mounjaro injections, with insights into managing stock and pharmacy relationships.
Why Ozempic Works Better for Some: The Role of Eating Behaviour
A recent Japanese study reveals that the success of GLP-1 drugs like Ozempic in managing type 2 diabetes and weight loss may depend on why people overeat, highlighting the importance of eating behaviour in treatment outcomes.
Lived Experiences of Weight Maintenance After Stopping GLP-1 Medications
Community members share personal experiences on maintaining weight loss after discontinuing GLP-1 medications, highlighting challenges and lifestyle adaptations.
Understanding New Style 10mg Mounjaro Pens and the 'Golden Dose' Experience
Recent discussions reveal changes in 10mg Mounjaro pens, including new designs and the disappearance of the 'golden dose'. This article explores user experiences and practical insights.
Stanford Researchers Identify Natural Peptide That May Influence Appetite Regulation
Stanford Medicine scientists have discovered a naturally occurring peptide, BRP, that shows potential to suppress appetite and reduce body weight in animal models through targeted brain pathways, distinct from existing drugs like semaglutide.